Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000649217 | SCV000771042 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-12-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001579748 | SCV001812218 | likely benign | not provided | 2020-09-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002449073 | SCV002752933 | likely benign | Cardiovascular phenotype | 2022-03-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome Diagnostics Laboratory, |
RCV001579748 | SCV001808379 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001579748 | SCV001918339 | uncertain significance | not provided | no assertion criteria provided | clinical testing |